- Home
- BLRX vs GENK Comparison
BLRX vs GENK Comparison
Compare BLRX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- GENK
- Stock Information
- Founded
- BLRX 2003
- GENK 2011
- Country
- BLRX Israel
- GENK United States
- Employees
- BLRX N/A
- GENK 2700
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- BLRX Health Care
- GENK Consumer Discretionary
- Exchange
- BLRX Nasdaq
- GENK Nasdaq
- Market Cap
- BLRX 17.0M
- GENK 16.3M
- IPO Year
- BLRX 2011
- GENK 2023
- Fundamental
- Price
- BLRX $3.67
- GENK $3.12
- Analyst Decision
- BLRX Strong Buy
- GENK Strong Buy
- Analyst Count
- BLRX 2
- GENK 2
- Target Price
- BLRX $19.00
- GENK $7.00
- AVG Volume (30 Days)
- BLRX 32.7K
- GENK 49.3K
- Earning Date
- BLRX 08-14-2025
- GENK 08-06-2025
- Dividend Yield
- BLRX N/A
- GENK 3.86%
- EPS Growth
- BLRX N/A
- GENK N/A
- EPS
- BLRX N/A
- GENK N/A
- Revenue
- BLRX $17,251,000.00
- GENK $216,137,000.00
- Revenue This Year
- BLRX N/A
- GENK $12.35
- Revenue Next Year
- BLRX N/A
- GENK $14.62
- P/E Ratio
- BLRX N/A
- GENK N/A
- Revenue Growth
- BLRX 1.19
- GENK 10.67
- 52 Week Low
- BLRX $2.30
- GENK $3.10
- 52 Week High
- BLRX $26.80
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- BLRX 44.89
- GENK 34.86
- Support Level
- BLRX $3.42
- GENK $3.15
- Resistance Level
- BLRX $3.79
- GENK $3.39
- Average True Range (ATR)
- BLRX 0.25
- GENK 0.14
- MACD
- BLRX 0.02
- GENK 0.00
- Stochastic Oscillator
- BLRX 47.17
- GENK 4.17
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.